Purchase Order 75N98026P01150
Award Date 8/12/26
Potential Completion Date 8/11/27
Potential Value $345K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10013, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Human Genome Research Institute awarded a purchase order to Oxford Nanopore Technologies Inc. for $50,065.00 on September 7, 2017, for an Oxford Nanopore Starter Pack—a device providing ultra-long read DNA and RNA sequencing using nanopores. Work is performed in Bethesda, Maryland. The order carries a firm fixed price and was scheduled for completion by October 20, 2017.</p>
- <p>The National Human Genome Research Institute awarded a purchase order to Oxford Nanopore Technologies Inc. for $24,200 on August 8, 2018, with completion on September 7, 2018. Work is performed in North Bethesda, Maryland. The order procures genomic sequencing instruments, consumables, or reagents consistent with the vendor's core product lines of next-generation sequencing platforms, flow cells, ligation kits, and related laboratory supplies.</p>
- The National Human Genome Research Institute awarded a purchase order to Oxford Nanopore Technologies Inc. for $165,000 on April 18, 2019, with a completion date of July 31, 2019. No set-aside applied. Place of performance is Cambridge, Massachusetts. The order procures next-generation sequencing instruments, consumables, and reagents—specifically PromethION 24 platform equipment and compatible flow cell packs and library preparation reagents for genomic sequencing research. The solicitation was...
- The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $24,264 purchase order to Oxford Nanopore Technologies Inc. for the delivery of unspecified products or services. Performance will take place in New York, NY under a firm fixed price arrangement concluding on September 29, 2023. As the NIH/NHGRI supports genomic research to analyze DNA and interpret the book of life, this contract is likely to provide Oxford Nanopore's...
- <p>The National Human Genome Research Institute awarded a purchase order to Oxford Nanopore Technologies Inc. for $24,200 on January 16, 2019, with ultimate completion on March 11, 2019. Performance occurs at North Bethesda, Maryland. The order is firm fixed price with no set-aside designation. Oxford Nanopore supplies next-generation genomic sequencing instruments, consumables, and reagents to federal research agencies, competing full-and-open across civilian health and research customers.</p>
- <p>The National Human Genome Research Institute awarded a purchase order to Oxford Nanopore Technologies Inc. valued at $10,000 on August 6, 2018, with completion on August 8, 2019. No set-aside was used. Place of performance is Bethesda, Maryland. The order is a firm-fixed-price purchase for next-generation sequencing instruments, consumables, or reagents—Oxford Nanopore's core product lines for federal research customers.</p>
- The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $185,835 firm fixed-price purchase order to Oxford Nanopore Technologies Inc. for the delivery of PromethION flow cell packs for long-read DNA and RNA/cDNA sequencing. Per the solicitation, the Government sought these products and associated packaging, marking, shipping, and delivery services to 251 Bayview Blvd in Baltimore, Maryland within 90 days of order receipt. As specified,...
- <p>The National Institute on Aging awarded a purchase order to Oxford Nanopore Technologies Inc. on July 21, 2026 for long sequencing kits, valued at $228,645.00 and firm-fixed-priced, with an ultimate completion date of July 20, 2027. Place of performance is Baltimore, Maryland. The order procures long-read sequencing consumables and reagents compatible with Oxford Nanopore sequencing platforms, supporting genomic research initiatives.</p>
- The National Institutes of Health, Office of Acquisitions, awarded a purchase order to Oxford Nanopore Technologies Inc. on June 10, 2026, for sequencing kits and consumables, with a ceiling value of $252,560.00 and a period of performance extending to October 10, 2026. The procurement, issued under FAR 12.603 as a non-competitive, brand-name acquisition, covers 72 units of PromethION Flow Cells Packs DNA (catalog number FLO-PRO114M) and 48 units of cDNA-PCR Sequencing Kit V14 (catalog number...
- The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $35,000 firm fixed price purchase order to Oxford Nanopore Technologies Inc. for a software license and device warranty to support the Oxford Nanopore Promethion 24A sequencing platform. The contract has a period of performance from January 19, 2024 through January 19, 2025. Oxford Nanopore Technologies Inc. will deliver the requested products and services as the prime...
The National Human Genome Research Institute awarded a purchase order to Oxford Nanopore Technologies Inc. for $345,390 on August 12, 2026, for PromethION flow cell packs (RNA and DNA variants), direct RNA sequencing kits, RNA barcoding kits, and ultra-long and ligation DNA sequencing kits. Performance occurs in New York, New York, with completion by August 11, 2027. The order is firm fixed price with no set-aside category.
Generated 8/20/26, 11:17 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $345.4k | 7/29/26 |